Indeed, MITF is essential for the maintenance of oncogenic BRAF‐driven melanoma in vivo (Lister et al., 2014), and the level of MAPK pathway activation appears to be critical for MITF abundance and function in melanoma cells (Figure 2). Here, BRAF is linked to melanoma.